Clinical Scorecard: Medications for Managing Sleep in Critical Illness and Aftercare

At a Glance

Key Highlights

• Sleep loss in critical illness is linked to poor ICU outcomes including delirium and physiological disturbances.
• Non-pharmacologic sleep bundles are the gold standard; medications should be reserved for cases where these fail.
• Pharmacologic sleep aids have shown disappointing results and may increase risks such as delirium and falls.

Guideline-Based Recommendations

Diagnosis

• Recognize sleep disruption as multifactorial involving circadian and homeostatic dysregulation.
• Consider the bidirectional relationship between sleep quality and ICU delirium.

Management

• Implement bundled non-pharmacologic interventions to improve sleep before considering medications.
• Use hypnotics targeting the arousal/sleep pathway cautiously, acknowledging limited efficacy and potential harms.
• Consider melatonin supplementation or melatonin receptor agonists to enhance circadian rhythm (chronotropy).
• Explore wakefulness-promoting strategies to consolidate sleep pressure at night.

Monitoring & Follow-up

• Monitor for unintended consequences of sleep medications including delirium and falls.
• Assess sleep quality and delirium incidence regularly during ICU stay.

Risks

• Polypharmacy increases risk of poor clinical outcomes in critically ill patients.
• Sedative medications may induce sedation distinct from natural sleep and contribute to delirium.
• Sleep medications may increase risk of falls and delirium.

Patient & Prescribing Data

Critically ill ICU patients often prescribed 8–12 medications on average

Medications specifically for sleep have limited efficacy and may worsen outcomes; non-pharmacologic measures preferred

Clinical Best Practices

• Prioritize non-pharmacologic sleep interventions bundled together before initiating pharmacotherapy.
• Be cautious with hypnotics such as GABA agonists (propofol, benzodiazepines) as they do not reliably improve sleep quality.
• Consider melatonin or melatonin receptor agonists to support circadian rhythm restoration.
• Recognize that sedation under medications differs from natural restorative sleep.
• Monitor patients closely for delirium and adverse effects when using sleep medications.

References

• Sleep loss linked to poor ICU outcomes
• Non-pharmacologic sleep bundles as gold standard
• Polypharmacy and medication complexity in ICU
• Sedation distinct from sleep
• Sleep disruption and delirium relationship
• Sleep improvement reduces delirium incidence
• Circadian and homeostatic disruption effects
• Pharmacologic targets in sleep pathway